Long-term partner Acton Capital (for whom I act as a venture partner for North-America) has…
Version One
As the Internet evolves, the venture capital business starts evolving and we have been seeing more and more investors focusing on growth and late stages in the past few years. This is exactly the step that our partners over in Germany have taken in the past months: after having managed the corporate venture capital business […]
Long-term partner Acton Capital (for whom I act as a venture partner for North-America) has…
I am excited to announce today the launch of Version One Ventures, a new $15 million micro-VC…
As the Internet evolves, the venture capital business starts evolving and we have been seeing more and more investors focusing on growth and late stages in the past few years. This is exactly the step that our partners over in Germany have taken in the past months: after having managed the corporate venture capital business for Hubert Burda Media with a focus on early-stage companies (Burda Digital Ventures) for the past several years, the team around Paul-Bernhard Kallen and Christoph Braun is now raising a second fund which targets later stage companies with an established track record of revenues and profitability (Acton Capital Partners). Hubert Burda Media is one of the largest investors in this new fund that continues to focus on Internet and mobile-based, consumer-oriented businesses. 20 to 30 percent of the committed fund will be invested outside Europe and mainly in North-America (and through W Media Ventures). This means for us that we will increasingly focus on late and growth stage deals in our region (some past deals in this category include AbeBooks, Suite101 and Nexopia) but will continue to look at selected early-stage opportunities.
Health / Biology, Portfolio, Version One
Shifting healthcare systems from reactive to proactive care is critical – the best outcomes occur when people can take action early, before a condition becomes a diagnosis. That’s why we are excited to announce that we have led a $2.5m pre-seed round for NiaHealth and are thrilled that they are coming out of stealth and […]
We are continually refining our thesis on healthcare, from looking at clinical-grade at-home diagnostics to biotech and…
Over the past year, some of the most interesting and intellectually-stimulating pitches we heard have…